Advanced search
Publication Cover
Annals of Medicine Volume 48, 2016 - Issue 8
Submit an article Journal homepage
7,657
Views
77
CrossRef citations to date
0
Altmetric
Review Article

Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?

Olga PivovarovaDepartment of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; ;Department of Endocrinology, Diabetes and Nutrition, Campus Benjamin Franklin, Charité University Medicine, Berlin, Germany; ;German Center for Diabetes Research (DZD), München, Germany; Correspondence[email protected]
View further author information
,
Annika HöhnGerman Center for Diabetes Research (DZD), München, Germany; ;Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; View further author information
,
Tilman GruneGerman Center for Diabetes Research (DZD), München, Germany; ;Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; ;German Center for Cardiovascular Research (DZHK), Berlin, GermanyView further author information
,
Andreas F.H. PfeifferDepartment of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; ;Department of Endocrinology, Diabetes and Nutrition, Campus Benjamin Franklin, Charité University Medicine, Berlin, Germany; ;German Center for Diabetes Research (DZD), München, Germany; View further author information
&
Natalia RudovichDepartment of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; ;Department of Endocrinology, Diabetes and Nutrition, Campus Benjamin Franklin, Charité University Medicine, Berlin, Germany; ;German Center for Diabetes Research (DZD), München, Germany; View further author information
Pages 614-624 | Received 31 Mar 2016, Accepted 25 May 2016, Published online: 19 Jun 2016

Citations (77)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mohammed Baqur S. Al-Shuhaib, Sarfaraz Alam, Salman Ali Khan, Hayder O. Hashim, Daniel H. Obayes & Jafar M. B. Al-Shuhaib. (2023) Masoprocol: a promising candidate for targeting insulin resistance by inhibiting resistin with optimal druglikeness Potentials: an in silico approach. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now
Longjian Liu, Stella L. Volpe, Jennifer A Ross, Jessica A Grimm, Elisabeth J Van Bockstaele & Howard J Eisen. (2022) Dietary sugar intake and risk of Alzheimer's disease in older women. Nutritional Neuroscience 25:11, pages 2302-2313.
Read now

Articles from other publishers (75)

Jiao-jiao Wu, Li Zhang, Dong Liu, Jia Xia, Yu Yang, Fei Tang, Lu Chen, Hui Ao & Cheng Peng. (2024) Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease. Journal of Ethnopharmacology 318, pages 116955.
Crossref
Paulo Matafome & Tamaeh Monteiro-Alfredo. 2024. Glycolysis. Glycolysis 297 319 .
Sweta Priyadarshini Pradhan, Pratap Kumar Sahu & Anindita Behera. (2023) New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer’s disease. Molecular and Cellular Biochemistry 478:12, pages 2739-2762.
Crossref
Miriam Corraliza-Gomez, Teresa Bermejo, Jingtao Lilue, Noelia Rodriguez-Iglesias, Jorge Valero, Irene Cozar-Castellano, Eduardo Arranz, Diego Sanchez & Maria Dolores Ganfornina. (2023) Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging. Journal of Neuroinflammation 20:1.
Crossref
Yue Tian, Guangchan Jing & Mengren Zhang. (2023) Insulin-degrading enzyme: Roles and pathways in ameliorating cognitive impairment associated with Alzheimer's disease and diabetes. Ageing Research Reviews 90, pages 101999.
Crossref
Joseph Nowell, Eleanor Blunt, Dhruv Gupta & Paul Edison. (2023) Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease. Ageing Research Reviews 89, pages 101979.
Crossref
Alev Duygu Acun, Deniz Kantar, Hakan Er, Orhan Erkan, Narin Derin & Piraye Yargıcoglu. (2023) Investigation of Cyclo-Z Therapeutic Effect on Insulin Pathway in Alzheimer's Rat Model: Biochemical and Electrophysiological Parameters. Molecular Neurobiology 60:7, pages 4030-4048.
Crossref
Mohamed Alrouji, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nada A. Ashour, Majid S. Jabir, Walaa A. Negm & Gaber El-Saber Batiha. (2023) Metformin role in Parkinson’s disease: a double-sword effect. Molecular and Cellular Biochemistry.
Crossref
Kai Li, Jing Xu, Meiduo Zhao, Jingtao Wu, Yayuan Mei, Quan Zhou, Jiaxin Zhao, Yanbing Li, Ming Yang & Qun Xu. (2023) Serum cystatin C and mild cognitive impairment: The mediating role of glucose homeostasis. Frontiers in Aging Neuroscience 15.
Crossref
Triana Espinosa-Jiménez, Amanda Cano, Elena Sánchez-López, Jordi Olloquequi, Jaume Folch, Mònica Bulló, Ester Verdaguer, Carme Auladell, Caterina Pont, Diego Muñoz-Torrero, Antoni Parcerisas, Antoni Camins & Miren Ettcheto. (2023) A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet. Cell & Bioscience 13:1.
Crossref
Ji Hye Yoon, JooHyun Hwang, Sung Un Son, Junhyuk Choi, Seung-Won You, Hyunwoo Park, Seung-Yun Cha & Sungho Maeng. (2023) How Can Insulin Resistance Cause Alzheimer’s Disease?. International Journal of Molecular Sciences 24:4, pages 3506.
Crossref
Joseph Nowell, Eleanor Blunt & Paul Edison. (2022) Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease. Molecular Psychiatry 28:1, pages 217-229.
Crossref
Shino Nemoto, Tetsuya Kubota & Hiroshi Ohno. (2022) Metabolic differences and differentially expressed genes between C57BL/6J and C57BL/6N mice substrains. PLOS ONE 17:12, pages e0271651.
Crossref
Saikat Dewanjee, Pratik Chakraborty, Hiranmoy Bhattacharya, Leena Chacko, Birbal Singh, Anupama Chaudhary, Kalpana Javvaji, Saumya Ranjan Pradhan, Jayalakshmi Vallamkondu, Abhijit Dey, Rajkumar Singh Kalra, Niraj Kumar Jha, Saurabh Kumar Jha, P. Hemachandra Reddy & Ramesh Kandimalla. (2022) Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress. Free Radical Biology and Medicine 193, pages 134-157.
Crossref
Atrin Yousefizadeh, Gaia Piccioni, Amira Saidi, Viviana Triaca, Dalila Mango & Robert Nisticò. (2022) Pharmacological targeting of microglia dynamics in Alzheimer’s disease: Preclinical and clinical evidence. Pharmacological Research 184, pages 106404.
Crossref
Vishvas N. Patel, Mehul R. Chorawala, Maitri B. Shah, Kashvi C. Shah, Bhavarth P. Dave, Manal P. Shah & Tanvi M. Patel. (2022) Emerging Pathophysiological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: An Old Wine in a New Bottle. Journal of Alzheimer's Disease Reports 6:1, pages 349-357.
Crossref
Alessia Distefano, Giuseppe Caruso, Valentina Oliveri, Francesco Bellia, Diego Sbardella, Gabriele Antonio Zingale, Filippo Caraci & Giuseppe Grasso. (2022) Neuroprotective Effect of Carnosine Is Mediated by Insulin-Degrading Enzyme. ACS Chemical Neuroscience 13:10, pages 1588-1593.
Crossref
Alonso Sánchez-Cruz, María D. Hernández-Fuentes, Cayetana Murillo-Gómez, Enrique J. de la Rosa & Catalina Hernández-Sánchez. (2022) Possible Role of Insulin-Degrading Enzyme in the Physiopathology of Retinitis Pigmentosa. Cells 11:10, pages 1621.
Crossref
Adriana Sevcuka, Kenneth White & Cassandra Terry. (2022) Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus. Life 12:4, pages 583.
Crossref
Laetitia Lesire, Florence Leroux, Rebecca Deprez-Poulain & Benoit Deprez. (2022) Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?. Cells 11:7, pages 1228.
Crossref
Mariem Ghoula, Nathalie Janel, Anne-Claude Camproux & Gautier Moroy. (2022) Exploring the Structural Rearrangements of the Human Insulin-Degrading Enzyme through Molecular Dynamics Simulations. International Journal of Molecular Sciences 23:3, pages 1746.
Crossref
Hua-Lin Zhou, Richard T. Premont & Jonathan S. Stamler. (2021) The manifold roles of protein S-nitrosylation in the life of insulin. Nature Reviews Endocrinology 18:2, pages 111-128.
Crossref
Ancuta-Veronica Lupaescu, Monica Iavorschi & Mihai Covasa. (2022) The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease. Pharmaceutics 14:2, pages 235.
Crossref
P. Vatsa, R. Negi, U. A. Ansari, V. K. Khanna & A. B. Pant. (2021) Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders. Molecular Neurobiology 59:1, pages 459-474.
Crossref
Victoria García-Morales, Anabel González-Acedo, Lucía Melguizo-Rodríguez, Teresa Pardo-Moreno, Víctor Javier Costela-Ruiz, María Montiel-Troya & Juan José Ramos-Rodríguez. (2021) Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease. Biomedicines 9:12, pages 1910.
Crossref
Luís Sousa, Mariana Guarda, Maria João Meneses, M Paula Macedo & Hugo Vicente Miranda. (2021) Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases. The Journal of Pathology 255:4, pages 346-361.
Crossref
Yanbo Fan, Brooke N. Wolford, Haocheng Lu, Wenying Liang, Jinjian Sun, Wei Zhou, Oren Rom, Anubha Mahajan, Ida Surakka, Sarah E. Graham, Zhipeng Liu, Hyunbae Kim, Shweta Ramdas, Lars G. Fritsche, Jonas B. Nielsen, Maiken Elvestad Gabrielsen, Kristian Hveem, Dongshan Yang, Jun Song, Minerva T. Garcia-Barrio, Jifeng Zhang, Wanqing Liu, Kezhong Zhang, Cristen J. Willer & Y. Eugene Chen. (2021) Type 2 diabetes sex-specific effects associated with E167K coding variant in TM6SF2. iScience 24:11, pages 103196.
Crossref
Eugenio Barone, Fabio Di Domenico, Marzia Perluigi & D. Allan Butterfield. (2021) The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease. Free Radical Biology and Medicine 176, pages 16-33.
Crossref
Janine Mett, Anna A. Lauer, Daniel Janitschke, Lea V. Griebsch, Elena L. Theiss, Heike S. Grimm, Hennariikka Koivisto, Heikki Tanila, Tobias Hartmann & Marcus O. W. Grimm. (2021) Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme. Cells 10:11, pages 2941.
Crossref
Marleigh Hefner, Vineet Baliga, Kailinn Amphay, Daniela Ramos & Vijay Hegde. (2021) Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology. Frontiers in Aging Neuroscience 13.
Crossref
Peng-Fei Wu, Xing-Hao Zhang, Ping Zhou, Rui Yin, Xiao-Ting Zhou & Wan Zhang. (2021) Growth Differentiation Factor 15 Is Associated With Alzheimer’s Disease Risk. Frontiers in Genetics 12.
Crossref
Maria Assunta Potenza, Luca Sgarra, Vanessa Desantis, Carmela Nacci & Monica Montagnani. (2021) Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?. Antioxidants 10:8, pages 1257.
Crossref
Xiuxiu Huang, Xiaoyan Zhao, Bei Li, Ying Cai, Shifang Zhang, Fang Yu & Qiaoqin Wan. (2021) Biomarkers for evaluating the effects of exercise interventions in patients with MCI or dementia: A systematic review and meta-analysis. Experimental Gerontology 151, pages 111424.
Crossref
Zenghui Wei, Jagadish Koya & Sandra E. Reznik. (2021) Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms. Frontiers in Neuroscience 15.
Crossref
Ana P.D. Taschetto, Priscila L. Zimath, Renata Silvério, Cristiane dos Santos, Antonio C. Boschero, Gustavo J. dos Santos & Alex Rafacho. (2021) Reduced insulin sensitivity and increased β/α cell mass is associated with reduced hepatic insulin-degrading enzyme activity in pregnant rats. Life Sciences 277, pages 119509.
Crossref
Suélen Santos Alves, Rui Milton Patrício da Silva-Junior, Gabriel Servilha-Menezes, Jan Homolak, Melita Šalković-Petrišić & Norberto Garcia-Cairasco. (2021) Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses. Journal of Alzheimer's Disease 82:1, pages 71-105.
Crossref
Oluwole B. Akawa, Temitayo I. Subair, Opeyemi S. Soremekun, Fisayo A. Olotu & Mahmoud E. S. Soliman. (2021) Structural alterations in the catalytic core of hSIRT2 enzyme predict therapeutic benefits of Garcinia mangostana derivatives in Alzheimer's disease: molecular dynamics simulation study . RSC Advances 11:14, pages 8003-8018.
Crossref
Karla Isabel Lira-De León, Alma Delia Bertadillo-Jilote, David Gustavo García-Gutiérrez & Marco Antonio Meraz-Ríos. 2021. Neurodegenerative Diseases - Molecular Mechanisms and Current Therapeutic Approaches. Neurodegenerative Diseases - Molecular Mechanisms and Current Therapeutic Approaches.
Beatriz Merino, Cristina M. Fernández-Díaz, Cristina Parrado-Fernández, Carlos M. González-Casimiro, Tamara Postigo-Casado, Carmen D. Lobatón, Malcolm A. Leissring, Irene Cózar-Castellano & Germán Perdomo. (2020) Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice. Metabolism 113, pages 154352.
Crossref
Osman Shabir, Tobias A. Moll, Martyna M. Matuszyk, Beth Eyre, Manmohi D. Dake, Jason Berwick & Sheila E. Francis. (2020) Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia. Mechanisms of Ageing and Development 192, pages 111361.
Crossref
Xia Tong, Shuyun Shi, Chaoying Tong, Ali Iftikhar, Ruiqing Long & Yongfeng Zhu. (2020) Quantum/carbon dots-based fluorescent assays for enzyme activity. TrAC Trends in Analytical Chemistry 131, pages 116008.
Crossref
Tuuli-Maria Sonninen, Gundars Goldsteins, Nihay Laham-Karam, Jari Koistinaho & Šárka Lehtonen. (2020) Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases. Cells 9:10, pages 2183.
Crossref
Kinga Hartman, Przemyslaw Mielczarek, Marek Smoluch & Jerzy Silberring. (2020) Inhibitors of neuropeptide peptidases engaged in pain and drug dependence. Neuropharmacology 175, pages 108137.
Crossref
Hans-Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny & Johann Steiner. (2019) Binding varicella zoster virus: an underestimated facet of insulin-degrading enzyme´s implication for Alzheimer´s disease pathology?. European Archives of Psychiatry and Clinical Neuroscience 270:4, pages 495-496.
Crossref
Sunpreet Kaur, Puneet Kumar & Shamsher Singh. (2020) Oxidative Stress Targeting Amyloid Beta Accumulation and Clearance in Alzheimer’s Disease: Insight into Pathological Mechanisms and Therapeutic Strategies. Current Psychopharmacology 9:1, pages 22-42.
Crossref
Wenyue Su, Qian Zhou, Yubin Wang, Athar Chishti, Qingshun Q. Li, Sujay Dayal, Shayan Shiehzadegan, Ariel Cheng, Clare Moore, Xiaoning Bi & Michel Baudry. (2020) Deletion of the Capn1 Gene Results in Alterations in Signaling Pathways Related to Alzheimer’s Disease, Protein Quality Control and Synaptic Plasticity in Mouse Brain. Frontiers in Genetics 11.
Crossref
Balamurugan Dhayalan, Yen‐Shan Chen, Nelson B. Phillips, Mamuni Swain, Nischay K. Rege, Ali Mirsalehi, Mark Jarosinski, Faramarz Ismail‐Beigi, Norman Metanis & Michael A. Weiss. (2020) Reassessment of an Innovative Insulin Analogue Excludes Protracted Action yet Highlights the Distinction between External and Internal Diselenide Bridges. Chemistry – A European Journal 26:21, pages 4695-4700.
Crossref
Pooja Patil, Ashima Thakur, Abha Sharma & Swaran Jeet Singh Flora. (2019) Natural products and their derivatives as multifunctional ligands against Alzheimer's disease. Drug Development Research 81:2, pages 165-183.
Crossref
Annika Höhn, Antonella Tramutola & Roberta Cascella. (2020) Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress. Oxidative Medicine and Cellular Longevity 2020, pages 1-21.
Crossref
Yanan Sun, Cao Ma, Hui Sun, Huan Wang, Wei Peng, Zibo Zhou, Hongwei Wang, Chenchen Pi, Yingai Shi & Xu He. (2020) Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer’s Disease. Journal of Diabetes Research 2020, pages 1-12.
Crossref
Rania M. Khalil, Abla Ebeid, Hassan Fayed & Sherien Abd-Elhady. (2019) Metformin: New Insights into Alzheimer Disease Protection. Asian Journal of Biochemistry 15:1, pages 21-27.
Crossref
Yoav Y. Broza, Xi Zhou, Miaomiao Yuan, Danyao Qu, Youbing Zheng, Rotem Vishinkin, Muhammad Khatib, Weiwei Wu & Hossam Haick. (2019) Disease Detection with Molecular Biomarkers: From Chemistry of Body Fluids to Nature-Inspired Chemical Sensors. Chemical Reviews 119:22, pages 11761-11817.
Crossref
Cristina M. Fernández-Díaz, Beatriz Merino, José F. López-Acosta, Pilar Cidad, Miguel A. de la Fuente, Carmen D. Lobatón, Alfredo Moreno, Malcolm A. Leissring, Germán Perdomo & Irene Cózar-Castellano. (2019) Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity. American Journal of Physiology-Endocrinology and Metabolism 317:5, pages E805-E819.
Crossref
Xijun Chen, Hui Li, Qing Yang, Xingcheng Lan, Jifeng Wang, Zhanhong Cao, Xiaozheng Shi, Jing Li, Mo Kan, Xiaobo Qu & Na Li. (2019) Ginsenoside compound K ameliorates Alzheimer’s disease in HT22 cells by adjusting energy metabolism. Molecular Biology Reports 46:5, pages 5323-5332.
Crossref
Gifty M. Jojo & Gowthamarajan Kuppusamy. (2019) Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease. Journal of Clinical Pharmacy and Therapeutics 44:3, pages 337-348.
Crossref
Gifty M. Jojo, Gowthamarajan Kuppusamy, Kousalya Selvaraj & Uday Krishna Baruah. (2019) Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs. Journal of Diabetes & Metabolic Disorders 18:1, pages 229-242.
Crossref
Hugo McGurran, Jordan M. Glenn, Erica N. Madero & Nicholas T. Bott. (2019) Prevention and Treatment of Alzheimer’s Disease: Biological Mechanisms of Exercise. Journal of Alzheimer's Disease 69:2, pages 311-338.
Crossref
Sonia M. Najjar & Germán Perdomo. (2019) Hepatic Insulin Clearance: Mechanism and Physiology. Physiology 34:3, pages 198-215.
Crossref
Dmitrii V. Kalinin, Oriana Agoglitta, Hélène Van de Vyver, Jelena Melesina, Stefan Wagner, Burkhard Riemann, Michael Schäfers, Wolfgang Sippl, Bettina Löffler & Ralph Holl. (2019) Proline-based hydroxamates targeting the zinc-dependent deacetylase LpxC: Synthesis, antibacterial properties, and docking studies. Bioorganic & Medicinal Chemistry 27:10, pages 1997-2018.
Crossref
Smriti Gupta, Nitin Kumar Singhal, Subramaniam Ganesh & Rajat Sandhir. (2019) Extending Arms of Insulin Resistance from Diabetes to Alzheimer’s Disease: Identification of Potential Therapeutic Targets. CNS & Neurological Disorders - Drug Targets 18:3, pages 172-184.
Crossref
Maria João Meneses, Diego O. Borges, Tânia R. Dias, Fátima O. Martins, Pedro F. Oliveira, M. Paula Macedo & Marco G. Alves. (2019) Knockout of insulin-degrading enzyme leads to mice testicular morphological changes and impaired sperm quality. Molecular and Cellular Endocrinology 486, pages 11-17.
Crossref
Jahangir Alam & Lalit Sharma. (2019) Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review. Current Drug Targets 20:3, pages 316-339.
Crossref
Yevgen Chornenkyy, Wang‐Xia Wang, Angela Wei & Peter T. Nelson. (2018) Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline. Brain Pathology 29:1, pages 3-17.
Crossref
Pran Kishore Deb, Omar Al-Attraqchi, Balakumar Chandrasekaran, Anant Paradkar & Rakesh K. Tekade. 2019. Basic Fundamentals of Drug Delivery. Basic Fundamentals of Drug Delivery 651 684 .
Lishuang Zhou, Wenfeng Liao, Hui Zeng, Yanli Yao, Xia Chen & Kan Ding. (2018) A pectin from fruits of Lycium barbarum L. decreases β-amyloid peptide production through modulating APP processing. Carbohydrate Polymers 201, pages 65-74.
Crossref
Pablo Villa-Pérez, Beatriz Merino, Cristina M. Fernández-Díaz, Pilar Cidad, Carmen D. Lobatón, Alfredo Moreno, Harrison T. Muturi, Hilda E. Ghadieh, Sonia M. Najjar, Malcolm A. Leissring, Irene Cózar-Castellano & Germán Perdomo. (2018) Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice. Metabolism 88, pages 1-11.
Crossref
Caixia Yin, Yuanyuan Deng, Yuangui Liu, Jianmei Gao, Lingli Yan & Qihai Gong. (2018) Icariside II Ameliorates Cognitive Impairments Induced by Chronic Cerebral Hypoperfusion by Inhibiting the Amyloidogenic Pathway: Involvement of BDNF/TrkB/CREB Signaling and Up-Regulation of PPARα and PPARγ in Rats. Frontiers in Pharmacology 9.
Crossref
Soren Hayrabedyan, Krassimira Todorova, Marialuigia Spinelli, Eytan R. Barnea & Martin Mueller. (2018) The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimer's disease. Oncotarget 9:74, pages 33884-33895.
Crossref
Valeria Lanza, Francesco Bellia & Enrico Rizzarelli. (2018) An inorganic overview of natural Aβ fragments: Copper(II) and zinc(II)-mediated pathways. Coordination Chemistry Reviews 369, pages 1-14.
Crossref
Zhening Zhang, Wenguang G Liang, Lucas J Bailey, Yong Zi Tan, Hui Wei, Andrew Wang, Mara Farcasanu, Virgil A Woods, Lauren A McCord, David Lee, Weifeng Shang, Rebecca Deprez-Poulain, Benoit Deprez, David R Liu, Akiko Koide, Shohei Koide, Anthony A Kossiakoff, Sheng Li, Bridget Carragher, Clinton S Potter & Wei-Jen Tang. (2018) Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme. eLife 7.
Crossref
João VM Malvezzi, Ingrid H Magalhaes, Silvia S Costa, Paulo A Otto, Carla Rosenberg, Debora R Bertola, Walter LM Fernandes, Angela M Vianna-Morgante & Ana CV Krepischi. (2018) KIF11 microdeletion is associated with microcephaly, chorioretinopathy and intellectual disability. Human Genome Variation 5:1.
Crossref
Kanza Benomar, Stéphanie Espiard, Camille Loyer, Arnaud Jannin & Marie-Christine Vantyghem. (2018) Hormones natriurétiques et syndrome métabolique : mise au point. La Presse Médicale 47:2, pages 116-124.
Crossref
Mirian A. Kurauti, José M. Costa-Júnior, Sandra M. Ferreira, Gustavo J. Santos, Carlos H. G. Sponton, Everardo M. Carneiro, Guilherme D. Telles, Mara P. T. Chacon-Mikahil, Cláudia R. Cavaglieri, Luiz F. Rezende & Antonio C. Boschero. (2017) Interleukin-6 increases the expression and activity of insulin-degrading enzyme. Scientific Reports 7:1.
Crossref
Satish K. GargDominique GiordanoTyler GalloViral N. Shah. (2017) New Medications for the Treatment of Diabetes. Diabetes Technology & Therapeutics 19:S1, pages S-128-S-140.
Crossref
Tomoko Ichiki & John C. Burnett Jr. (2017) Atrial Natriuretic Peptide　― Old But New Therapeutic in Cardiovascular Diseases ―. Circulation Journal 81:7, pages 913-919.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.